Eascra Biotech is advancing DNA-inspired nanomaterials developed with ISS National [...]

Kainova Therapeutics has dosed the first European patient in its [...]

Kainova Therapeutics has dosed the first patient in Europe in [...]

FoRx Therapeutics presents preclinical data on FORX-428, a PARG inhibitor [...]

One-carbon Therapeutics has signed a collaboration with Tempus to generate [...]

Insilico Medicine has nominated ISM6166 as a preclinical candidate, positioning [...]

Cue Biopharma and ImmunoScape have entered an exclusive collaboration and [...]

MaxCyte has entered a strategic platform licence with US biotech [...]

Lonza’s Synaffix has signed a licensing agreement with Qurient Therapeutics [...]

New alliance focuses on translation, process development and GMP-readiness for [...]